Búsqueda | Biblioteca Virtual en Salud

1.

Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer.

Ponce Aix, Santiago; Talbot, Denis; Govindan, Ramaswamy; Dols, Manuel Cobo; Postmus, Pieter E; Lewanski, Conrad; Bennouna, Jaafar; Fischer, Juergen R; Juan-Vidal, Oscar; Stewart, David J; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Reck, Martin; Ong, Teng Jin; Morgensztern, Daniel.

Future Oncol ; 16(12): 749-762, 2020 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-32228198

2.

Association between depth of response and survival in patients with advanced-stage non-small cell lung cancer treated with first-line chemotherapy.

Morgensztern, Daniel; Ko, Amy; O'Brien, Mary; Ong, Teng Jin; Waqar, Saiama N; Socinski, Mark A; Postmus, Pieter E; Bhore, Rafia.

Cancer ; 125(14): 2394-2399, 2019 07 15.

Artículo en Inglés | MEDLINE | ID: mdl-30933354

3.

Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial.

Spigel, David R; Jotte, Robert M; Aix, Santiago Ponce; Gressot, Laurent; Morgensztern, Daniel; McCleod, Michael; Socinski, Mark A; Daniel, Davey; Juan-Vidal, Oscar; Mileham, Kathryn F; West, Howard; Page, Ray; Reinmuth, Niels; Knoble, Jeanna; Chen, Tianlei; Bhore, Rafia; Wolfsteiner, Marianne; Ong, Teng Jin; Gridelli, Cesare; Thomas, Michael.

Clin Lung Cancer ; 22(1): 6-15.e4, 2021 01.

Artículo en Inglés | MEDLINE | ID: mdl-33097414

4.

nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis.

Langer, Corey J; Gajra, Ajeet; Gridelli, Cesare; Konduri, Kartik; Morgensztern, Daniel; Spigel, David; Talbot, Denis; Thomas, Michael; Weiss, Jared; Pilot, Richard; Bhore, Rafia; Wolfsteiner, Marianne; Ong, Teng Jin; Socinski, Mark.

Front Oncol ; 10: 485587, 2020.

Artículo en Inglés | MEDLINE | ID: mdl-33575203

5.

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+).

Morgensztern, Daniel; Dols, Manuel Cobo; Ponce Aix, Santiago; Postmus, Pieter E; Bennouna, Jaafar; Fischer, Jürgen R; Juan-Vidal, Oscar; Stewart, David J; Ardizzoni, Andrea; Bhore, Rafia; Wolfsteiner, Marianne; Reck, Martin; Talbot, Denis; Govindan, Ramaswamy; Ong, Teng Jin.

Front Oncol ; 10: 569715, 2020.

Artículo en Inglés | MEDLINE | ID: mdl-33643895

6.

Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer.

Wainberg, Zev A; Hochster, Howard S; Kim, Edward J; George, Ben; Kaylan, Aparna; Chiorean, E Gabriela; Waterhouse, David M; Guiterrez, Martin; Parikh, Aparna; Jain, Rishi; Carrizosa, Daniel Ricardo; Soliman, Hatem H; Lila, Thomas; Reiss, David J; Pierce, Daniel W; Bhore, Rafia; Banerjee, Sibabrata; Lyons, Larry; Louis, Chrystal U; Ong, Teng Jin; O'Dwyer, Peter J.

Clin Cancer Res ; 26(18): 4814-4822, 2020 09 15.

Artículo en Inglés | MEDLINE | ID: mdl-32554514

7.

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study.

Philip, Philip A; Lacy, Jill; Portales, Fabienne; Sobrero, Alberto; Pazo-Cid, Roberto; Manzano Mozo, José L; Kim, Edward J; Dowden, Scot; Zakari, Ahmed; Borg, Christophe; Terrebonne, Eric; Rivera, Fernando; Sastre, Javier; Bathini, Venu; López-Trabada, Daniel; Asselah, Jamil; Saif, Muhammad Wasif; Shiansong Li, Jack; Ong, Teng Jin; Nydam, Thomas; Hammel, Pascal.

Lancet Gastroenterol Hepatol ; 5(3): 285-294, 2020 03.

Artículo en Inglés | MEDLINE | ID: mdl-31953079

8.

Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer.

Goldman, Jonathan W; Waterhouse, David M; George, Ben; O'Dwyer, Peter J; Bhore, Rafia; Banerjee, Sibabrata; Lyons, Larry; Louis, Chrystal U; Ong, Teng Jin; Kelly, Karen.

Front Oncol ; 9: 1256, 2019.

Artículo en Inglés | MEDLINE | ID: mdl-31850192

9.

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial.

Gridelli, Cesare; Chen, Tianlei; Ko, Amy; O'Brien, Mary E; Ong, Teng Jin; Socinski, Mark A; Postmus, Pieter E.

Drug Des Devel Ther ; 12: 1445-1451, 2018.

Artículo en Inglés | MEDLINE | ID: mdl-29872267

10.

Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin.

Hirsh, Vera; Wan, Yin; Lin, Fang-Ju; Margunato-Debay, Sandra; Ong, Teng Jin; Botteman, Marc; Langer, Corey.

Clin Lung Cancer ; 19(5): 401-409.e4, 2018 09.

Artículo en Inglés | MEDLINE | ID: mdl-29903552

11.

nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2.

Gajra, Ajeet; Karim, Nagla Abdel; Mulford, Deborah A; Villaruz, Liza Cosca; Matrana, Marc Ryan; Ali, Haythem Y; Santos, Edgardo S; Berry, Tymara; Ong, Teng Jin; Sanford, Alexandra; Amiri, Katayoun; Spigel, David R.

Front Oncol ; 8: 253, 2018.

Artículo en Inglés | MEDLINE | ID: mdl-30087850

12.

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy.

Thomas, Michael; Spigel, David R; Jotte, Robert M; McCleod, Michael; Socinski, Mark A; Page, Ray D; Gressot, Laurent; Knoble, Jeanna; Juan, Oscar; Morgensztern, Daniel; Isla, Dolores; Kim, Edward S; West, Howard; Ko, Amy; Ong, Teng Jin; Trunova, Nataliya; Gridelli, Cesare.

Lung Cancer (Auckl) ; 8: 207-216, 2017.

Artículo en Inglés | MEDLINE | ID: mdl-29138610

13.

Monotherapy Administration of Sorafenib in Patients With Non-Small Cell Lung Cancer (MISSION) Trial: A Phase III, Multicenter, Placebo-Controlled Trial of Sorafenib in Patients with Relapsed or Refractory Predominantly Nonsquamous Non-Small-Cell Lung Cancer after 2 or 3 Previous Treatment Regimens.

Paz-Ares, Luis; Hirsh, Vera; Zhang, Li; de Marinis, Filippo; Yang, James Chih-Hsin; Wakelee, Heather A; Seto, Takashi; Wu, Yi-Long; Novello, Silvia; Juhász, Erszébet; Arén, Osvaldo; Sun, Yan; Schmelter, Thomas; Ong, Teng Jin; Peña, Carol; Smit, Egbert F; Mok, Tony S.

J Thorac Oncol ; 10(12): 1745-53, 2015 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-26743856

14.

Comparative assessment of gastrointestinal irritant potency in man of tin(II) chloride and tin migrated from packaging.

Boogaard, Peter J; Boisset, Michel; Blunden, Steve; Davies, Scot; Ong, Teng Jin; Taverne, Jean-Pierre.

Food Chem Toxicol ; 41(12): 1663-70, 2003 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-14563391

15.

Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer.

Paz-Ares, Luis G; Biesma, Bonne; Heigener, David; von Pawel, Joachim; Eisen, Timothy; Bennouna, Jaafar; Zhang, Li; Liao, Meilin; Sun, Yan; Gans, Steven; Syrigos, Kostas; Le Marie, Etienne; Gottfried, Maya; Vansteenkiste, Johan; Alberola, Vincente; Strauss, Uwe Phillip; Montegriffo, Elaine; Ong, Teng Jin; Santoro, Armando.

J Clin Oncol ; 30(25): 3084-92, 2012 Sep 01.

Artículo en Inglés | MEDLINE | ID: mdl-22851564

16.

Nutritional genomics.

Elliott, Ruan; Ong, Teng Jin.

BMJ ; 324(7351): 1438-42, 2002 Jun 15.

Artículo en Inglés | MEDLINE | ID: mdl-12065270

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar: